APOE and Alzheimer disease: However, some of these studies suggest that neurological effects depend on the apolipoprotein E4 (ApoE4) genotype, the most prevalent genetic risk factor for AD, because cognitive benefits have been demonstrated only among subjects who were ApoE4-negative [109,110].